References
- Jacoby H. I., Bonfilio A. C., Corcoran T., Lopez I., Scott M. K., Rosenfeld G. C. Fenoctimine, a new gastric antisecretory agent. Gastroenterology 1982; 82: 1092
- McKown L. A., Wu W. N. In‐vitro biotransformation of fenoctimine (Fn), a gastric anti‐sectretory agent. FASEB Journal 1992; A: 1883
- Renzi N. L., Wu W. N., Rigney J. P., Hills J. F., McKown L. A., Dvorchik B. H., O'Neill P. J. Comparative studies on the absorption, excretion and biotransformation of fenoctimine in mouse, rat, rabbit, dog and man. Pharmacologist 1983; 25: 114
- Scott M. K., Jacoby H. I., Bonfilio A. C., Corcoran T. W., Lopez I. S. Antisecretory activity of human, dog and rat metabolites of fenoctimine. Journal of Medicinal Chemistry 1987; 30: 894–899
- Testa B., Jenner P. Chemical and Biochemical Aspects, Drug Metabolism. Marcel Dekker. 1976; Vol. 4: 173–180
- Williams J. G., Robertson R. J., Milton‐Thompson G. J. Inhibition of food stimulated acid secretion by fenoctimine, a new anti‐secretory agent. British Journal Clinical Pharmacology 1983; 15: 673–676
- Williams J. G., Robertson R. J., Milton‐Thompson G. J., Holmann A., Dietrich U., Reinhart W., Halter F. Inhibition of gastric secretion by fenoctimine, a new anti‐secretory agent. Gut 1981; 22: A881
- Wu W. N., Ng K. T., Hills J. F., Chang S. Y., O'Neill P. J. Metabolism of fenoctimine (Fn) in the dog and man. Federation Proceedings 1985; 44: 1256
- Yeh S. Y., Krebs H. A. TLC identification and GLC determination of meperidine and its metabolites in biological fluids. Journal of Pharmaceutical Science 1981; 70: 482–486
- Yorgey K. A., Pritchard J. F., Renzi N. L., Dvorchik B. H. Evaluation of drug absorption and presystemic metabolism using an in situ intestinal preparation. Journal of Pharmaceutical Science 1986; 75: 869–872